Innovative Depression Treatments: IV Ketamine & Spravato® at Duluth TMS

For individuals struggling with treatment-resistant depression, anxiety, or PTSD, IV Ketamine and Spravato® offer groundbreaking solutions that provide hope and relief when traditional therapies fall short. At Duluth TMS, these advanced treatments are part of a comprehensive mental health care program designed to address the unique challenges of persistent mood disorders. IV Ketamine and Spravato® are revolutionizing the way depression is treated by targeting brain function in a way that is faster and more effective than conventional medications.

IV Ketamine therapy involves administering low doses of ketamine through an intravenous infusion under the supervision of a trained medical team. This method helps regulate brain activity and restore connections between neurons, which can reduce symptoms of depression, anxiety, and PTSD within hours or days. Spravato® (esketamine) is a prescription nasal spray derived from ketamine, approved by the FDA specifically for treatment-resistant depression. Used alongside oral antidepressants, Spravato® provides a quick-acting solution to alleviate severe depressive symptoms. Both treatments at Duluth TMS are carefully tailored to meet each patient’s needs, ensuring safety, comfort, and efficacy throughout the process.

Duluth TMS is committed to providing innovative and compassionate care with these cutting-edge therapies. By offering IV Ketamine and Spravato®, they give patients new hope for improved mental health and a better quality of life. These treatments are particularly beneficial for those who have not responded to traditional antidepressants or psychotherapy, offering a fast-acting alternative to reduce symptoms and foster long-term healing. At Duluth TMS, every patient receives a personalized treatment plan in a supportive and professional environment, making them a trusted resource for advanced mental health solutions. If you or a loved one is seeking effective relief from depression, explore the transformative potential of IV Ketamine and Spravato® at Duluth TMS.